Joint Development with Customers and New Products and Quality Improvements
First written in FY2016. 26 of 32 entries say "Restated". Latest entry: FY2025.
22 other companies' latest entry also says "Advanced".
- FY2025AdvancedAnnual report
「During the consolidated fiscal year, the company invested ¥1,747 million in R&D expenses.」
R&D expenses increased from ¥1,506 million in the previous fiscal year to ¥1,747 million. The company continued developing abrasives, functional fibers, piezoelectric sensors and new material molding methods. - FY2025-H1AdvancedAnnual report
「Total R&D expenses for the current consolidated interim period were ¥869 million.」
Although the company reported no material changes in its R&D activities, it recorded R&D expenses of ¥869 million. This was an increase from ¥689 million in the same period of the previous year. - FY2024-Q3RestatedAnnual report
「Total R&D expenses for the cumulative period through the third quarter of the current consolidated fiscal year were ¥1,062 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the third quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥1,062 million for the cumulative period through the third quarter of the current fiscal year. - FY2024-Q2RestatedAnnual report
「Total R&D expenses for the cumulative period through the second quarter of the current consolidated fiscal year were ¥689 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the second quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥689 million for the cumulative period through the second quarter of the current fiscal year. - FY2024-Q1RestatedAnnual report
「Total R&D expenses for the cumulative period through the first quarter of the current consolidated fiscal year were ¥350 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the first quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥350 million for the cumulative period through the first quarter of the current fiscal year. - FY2023AdvancedAnnual report
「During the consolidated fiscal year, the company invested ¥1,161 million in R&D expenses.」
R&D expenses increased from ¥1,080 million in the previous fiscal year to ¥1,161 million. The company continued R&D on abrasives, everyday clothing, piezoelectric sensors and other products. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the cumulative period through the third quarter of the current consolidated fiscal year were ¥815 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the third quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥815 million for the cumulative period through the third quarter of the current fiscal year. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the cumulative period through the second quarter of the current consolidated fiscal year were ¥532 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the second quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥532 million for the cumulative period through the second quarter of the current fiscal year. - FY2023-Q1RestatedAnnual report
「Total R&D expenses for the cumulative period through the first quarter of the current consolidated fiscal year were ¥263 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the first quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥263 million for the cumulative period through the first quarter of the current fiscal year. - FY2022-Q3RestatedAnnual report
「Total R&D expenses for the cumulative period through the third quarter of the current consolidated fiscal year were ¥790 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the third quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥790 million for the cumulative period through the third quarter of the current fiscal year. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative period through the second quarter of the current consolidated fiscal year were ¥534 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the second quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥534 million for the cumulative period through the second quarter of the current fiscal year. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the cumulative period through the first quarter of the current consolidated fiscal year were ¥272 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the first quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥272 million for the cumulative period through the first quarter of the current fiscal year. - FY2021RestatedAnnual report
「During the consolidated fiscal year, the company promoted R&D activities in areas including its abrasives business, taking a long-term approach to R&D for new product development and product quality improvements under an integrated manufacturing, sales and research structure. During the consolidated fiscal year, the company invested ¥1,080 million in R&D expenses.」
The company continued developing new products and improving quality under an integrated manufacturing, sales and research structure, and invested ¥1,080 million in R&D expenses. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the cumulative period through the third quarter of the current consolidated fiscal year were ¥800 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the third quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥800 million for the cumulative period through the third quarter of the current fiscal year. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the cumulative period through the second quarter of the current consolidated fiscal year were ¥526 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the second quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥526 million for the cumulative period through the second quarter of the current fiscal year. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the cumulative period through the first quarter of the current consolidated fiscal year were ¥260 million. There were no material changes in the status of the group’s R&D activities during the cumulative period through the first quarter of the current consolidated fiscal year.」
The company reported no material changes in its R&D activities and disclosed R&D expenses of ¥260 million for the cumulative period through the first quarter of the current fiscal year. - FY2020AdvancedAnnual report
「During the consolidated fiscal year, the company invested ¥1,220 million in R&D expenses.」
R&D expenses increased from ¥993 million in the previous fiscal year to ¥1,220 million. The company continued developing abrasives, clothing-type wearable devices, the use of robots in sewing processes, and high-performance injection molding technologies. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the cumulative period through the third quarter of the current consolidated fiscal year were ¥932 million.」
The company continued its R&D activities and invested ¥932 million during the cumulative period through the third quarter. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative period through the second quarter of the current consolidated fiscal year were ¥620 million.」
The company continued its R&D activities and invested ¥620 million during the cumulative period through the second quarter. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the cumulative period through the first quarter of the current consolidated fiscal year were ¥305 million.」
The company continued its R&D activities and invested ¥305 million during the cumulative period through the first quarter. - FY2019AdvancedAnnual report
「During the consolidated fiscal year, the company promoted R&D activities in areas including its abrasives business, taking a long-term approach to R&D for new product development and product quality improvements under an integrated manufacturing, sales and research structure. During the consolidated fiscal year, the company invested ¥993 million in R&D expenses.」
R&D expenses were ¥993 million. In addition to abrasives development, the company is advancing development of clothing-type wearable devices, the use of robots in sewing processes, and high-performance injection molding technologies and plastic components. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the cumulative period through the third quarter of the current consolidated fiscal year were ¥719 million.」
The company continued its R&D activities and invested ¥719 million during the cumulative period through the third quarter. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the cumulative period through the second quarter of the current consolidated fiscal year were ¥474 million.」
The company continued its R&D activities and reported R&D expenses of ¥474 million for the cumulative period through the second quarter of the consolidated fiscal year. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the cumulative period through the first quarter of the current consolidated fiscal year were ¥228 million.」
The company continued its R&D activities and reported R&D expenses of ¥228 million for the cumulative period through the first quarter. - FY2018RestatedAnnual report
「In the current consolidated fiscal year, research and development activities in areas including the abrasives business were pursued from a long-term perspective under an integrated manufacturing, sales and research structure, including research and development for new products and product quality improvements. The company invested ¥964 million in research and development expenses during the current consolidated fiscal year.」
The company continued new product development and quality improvements under an integrated manufacturing, sales and research structure, investing ¥964 million in research and development. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated period were ¥732 million.」
The company continued its research and development activities and reported research and development expenses of ¥732 million for the cumulative third quarter period. - FY2018-Q2RestatedAnnual report
「Total research and development expenses for the cumulative second quarter of the current consolidated period were ¥494 million.」
The company continued its research and development activities and reported research and development expenses of ¥494 million for the cumulative second quarter period. - FY2018-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current cumulative consolidated period were ¥256 million.」
The company continued its research and development activities and reported research and development expenses of ¥256 million for the cumulative first quarter period. - FY2017-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated period were ¥593 million.」
The company continued its research and development activities and reported research and development expenses of ¥593 million for the cumulative third quarter period. - FY2017-Q2RestatedAnnual report
「Total research and development expenses for the six-month period of the current consolidated fiscal year were ¥392 million.」
The company continued its research and development activities and reported research and development expenses of ¥392 million for the cumulative second quarter period. - FY2017-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current cumulative consolidated period were ¥202 million.」
The company continued its research and development activities and reported research and development expenses of ¥202 million for the first quarter of the current period. - FY2016First statedAnnual report
「Under an integrated manufacturing, sales and research structure, the company has pursued research and development for new products and product quality improvements from a long-term perspective. In the current consolidated fiscal year, it invested ¥886 million in research and development expenses.」
The company invested ¥886 million in research and development and is advancing development in abrasives, chemical products and synthetic chemicals.